Svigos J M, Cox L W, Kirkland J A, Harvey N D
Aust N Z J Obstet Gynaecol. 1978 Nov;18(4):253-8. doi: 10.1111/j.1479-828x.1978.tb00065.x.
A retrospective analysis of 91 patients with endometrial carcinoma is presented with emphasis on important factors in relation to survival. Patients with Stage 1 carcinoma were treated with a standardized mode of preoperative radiation and extended abdominal hysterectomy. An 87.1% 5-year survival rate was obtained for patients with well differentiated lesions, with only 1 patient developing a vault metastasis. The assessment of residual tumour after intracavity radiotherapy proved reliable in predicting prognosis and should prove of benefit in directing additional therapy for endometrial carcinoma.
本文对91例子宫内膜癌患者进行了回顾性分析，重点关注与生存相关的重要因素。I期癌患者采用标准化的术前放疗和扩大腹式子宫切除术治疗。高分化病变患者的5年生存率为87.1%，仅1例发生阴道残端转移。腔内放疗后残余肿瘤的评估在预测预后方面被证明是可靠的，并且在指导子宫内膜癌的进一步治疗中应会有帮助。
